Antiverse raises £3.5 M ($4.6 M) to advance generative AI antibody design platform

  • Post author:
  • Post category:uncategorized

Antiverse, a techbio company designing antibodies for challenging targets, today announced it has added £3.5 M ($4.6 M) to its seed funding.